Nichimo

Nichimo Co., Ltd. is a Japanese diversified company that maintains a specialized presence in the life sciences and healthcare sectors through its Biotics Business division and its subsidiary, Nichimo Biotics. The company leverages proprietary fermentation technologies utilizing Koji fungus and lactic acid bacteria to develop bioactive ingredients and functional food products derived from soy. Its lead products include AglyMax, a daidzein-rich isoflavone aglycone, and ImmuBalance, a fermented soy product designed for immune system modulation. These compounds have been the subject of multiple clinical trials and academic studies investigating their efficacy in treating menopausal symptoms, endometriosis, and allergic conditions. Nichimo serves as a global supplier of high-potency nutraceutical ingredients and continues to invest in clinical research to validate the therapeutic potential of its bioactives.